Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-046015

Director sold 177,135 shares at an average $38.25 ($6,775,149)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PIMSTONE SIMON N. Director 2022-08-12 Sale −43,135 $37.91 $1,635,248 140,000 D: show line 1 in the form
PIMSTONE SIMON N. Director 2022-08-12 Sale −47,000 $38.60 $1,814,200 93,000 D: show line 2 in the form
PIMSTONE SIMON N. Director 2022-08-12 Sale −1,000 $39.15 $39,150 92,000 D: show line 3 in the form
PIMSTONE SIMON N. Director 2022-08-15 Sale −33,942 $37.76 $1,281,650 58,058 D: show line 4 in the form
PIMSTONE SIMON N. Director 2022-08-16 Sale −32,058 $38.29 $1,227,501 26,000 D: show line 5 in the form
PIMSTONE SIMON N. Director 2022-08-16 Sale −20,000 $38.87 $777,400 6,000 D: show line 6 in the form
Open-market sales · 177,135 sh · avg $38.25 · $6,775,149
Loading xslF345X03/doc4.xml…